Picture of Thermogenesis Holdings logo

THMO — Thermogenesis Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
TechnologyHighly SpeculativeMicro Cap

Brief: Thermogenesis Announces Immunecyte Joint Venture Acquires Key Technologies To Develop Fully Human Polyclonal And Monoclonal Antibody Therapeutics For COVID-19

April 13 (Reuters) - Thermogenesis Holdings Inc  THMO.O :
    * THERMOGENESIS ANNOUNCES ITS IMMUNECYTE JOINT VENTURE
ACQUIRES
KEY TECHNOLOGIES TO DEVELOP FULLY HUMAN POLYCLONAL AND
MONOCLONAL ANTIBODY THERAPEUTICS FOR COVID-19

Source text for Eikon:  ID:nPn1vzQFNa 
Further company coverage:  THMO.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Thermogenesis Holdings

See all news